Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virology

Validation and Diagnostic Application of NS and HA Gene-Specific Real-Time Reverse Transcription-PCR Assays for Detection of 2009 Pandemic Influenza A (H1N1) Viruses in Clinical Specimens

Esa Rönkkö, Niina Ikonen, Mia Kontio, Minna Haanpää, Hannimari Kallio-Kokko, Laura Mannonen, Maija Lappalainen, Ilkka Julkunen, Thedi Ziegler
Esa Rönkkö
1Viral Infections Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: esa.ronkko@thl.fi
Niina Ikonen
1Viral Infections Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mia Kontio
1Viral Infections Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minna Haanpää
1Viral Infections Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannimari Kallio-Kokko
2Helsinki University Hospital, Laboratory Services, Department of Virology, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Mannonen
2Helsinki University Hospital, Laboratory Services, Department of Virology, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maija Lappalainen
2Helsinki University Hospital, Laboratory Services, Department of Virology, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilkka Julkunen
1Viral Infections Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thedi Ziegler
1Viral Infections Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.00259-11
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Real-time reverse transcription-PCR assays specific for the nonstructural (NS) and hemagglutinin (HA) genes of the 2009 pandemic influenza A (H1N1) virus were developed and evaluated with clinical samples from infected patients. The tests are characterized by high sensitivity and specificity and performed well throughout the first year of the 2009 pandemic.

TEXT

Soon after the emergence of the 2009 pandemic influenza A (H1N1) virus (1, 2, 6, 7), the WHO provided diagnostic kits (http://www.who.int/csr/resources/publications/swineflu/CDCrealtimeRTPCRprotocol_20090428.pdf) and the information necessary to develop PCRs (8, 12–14) for the identification of this novel virus.

Here we present an evaluation of real-time PCR formats for the specific detection of the 2009 pandemic influenza A (H1N1) virus in clinical specimens. The hemagglutinin (HA) and nonstructural (NS) genes were chosen as targets for these assays. The nucleotide sequences of these genes are sufficiently distinct from those of recently circulating seasonal H1N1 and other influenza viruses and offer opportunities to design primers and probes that specifically amplify HA and NS gene segments of the pandemic virus. NS gene-specific assays could be particularly useful should the virus mutate to a degree where current HA-based PCRs lose sensitivity.

Combined nasal and throat swabs from 343 patients infected with the influenza A (H1N1) 2009 virus and 32 quality assessment samples were available. A local influenza A (H1N1) 2009 virus (A/Finland/554/2009) isolate was propagated in MDCK cells (5, 10), and the culture supernatant was stored in aliquots at −70°C and used as a positive control.

PCRs targeting different regions of the NS (SW-NS-60, SW-NS-183, SW-NS-631) and HA (SW-H1-674, SW-H1-1076) genes of the influenza A (H1N1) 2009 virus were developed (Table 1). A matrix (M) gene-specific PCR, designated the IA M1 assay, that detects all subtypes of influenza A virus (9, 16) served as the reference method. The CDC SW H1 (3) HA-specific PCR was included in some experiments. The gene targets, nucleotide sequences, and oligonucleotide locations of the 5 PCR formats are shown in Table 1. Probes were 5′ labeled with the 6-carboxyfluorescein (FAM) fluorophore, and a black hole quencher was added to the 3′ end (Life Technologies, Carlsbad, CA; Oligomer, Helsinki, Finland). (For a sequence alignment of the NS genes of several viruses with the locations of the oligonucleotides used in the SW-NS-631 assay used in all diagnostic analyses, see Fig. S1 in the supplemental material.)

View this table:
  • View inline
  • View popup
Table 1.

Oligonucleotide sequences of the primers and probes used in real-time RT-PCR assays

RNA extracted from 100 μl of samples (RNeasy Mini Kit; Qiagen, Hilden, Germany) with a QIAcube instrument (Qiagen) was eluted in 50 μl, of which 10 μl was reverse transcribed (RevertAid enzyme; Fermentas, St. Leon-Rot, Germany) using random hexamer primers (Roche, Mannheim, Germany). cDNA was amplified with Maxima Probe quantitative PCR master mix (Fermentas). The thermal profile was 95°C for 15 min (enzyme activation) followed by 50 cycles of 95°C, 55°C, and 72°C, 45 s each step, on a Stratagene Mx3005P thermal cycler. The threshold was set at the level where the amplification curve of the positive control exceeded the baseline-corrected fluorescence during the third consecutive amplification cycle.

Neither the in-house PCRs nor the IA M1 and CDC SW H1 reference assays reacted with any samples found positive for adenovirus; parainfluenza virus types 1, 2, and 3; respiratory syncytial virus; metapneumovirus; or bocavirus by specific PCRs (results not shown). Furthermore, none of the assays specific for the pandemic virus reacted with any of several H5N1 viruses, with H7N3, H9N2, seasonal H1N1 or H3N2, or influenza B or C virus (see Table S1 in the supplemental material). However, all assays detected the three influenza A (H1N1) 2009 viruses in preliminary evaluations. The sensitivity of the assays was determined with dilutions of RNA from cultured A/Finland/554/2009 (H1N1) virus corresponding to 90 to 0.0009 PFU per reaction. Seven replicates of each dilution were tested in parallel. With 0.9 PFU, all seven replicates yielded a positive result with the IA M1, SW-NS631, and SW-H1-1076 assays (Table 2). Other in-house assays and the CDC SW H1 reference assay were slightly less sensitive.

View this table:
  • View inline
  • View popup
Table 2.

Sensitivity of the real-time RT-PCR assays described in terms of PFU/assay volume

The SW-NS-631 and IA M1 assays produced almost identical cycle threshold (CT) values for each of the 343 clinical samples positive for A (H1N1) 2009 virus.

Real-time reverse transcription (RT)-PCR formats developed for the specific identification of the influenza A (H1N1) 2009 virus were compared with an M gene-specific RT-PCR and with the reference test distributed through the WHO. Three conserved areas in the NS gene that distinguished the novel virus from other seasonal influenza viruses were chosen for the development of the assays described. The new tests proved to be highly specific and sensitive.

The assays specific for the HA and NS genes of the influenza A (H1N1) 2009 virus reacted exclusively with the novel pandemic viruses. Some cross-reactions between the influenza A (H1N1) 2009 virus and other influenza viruses have been observed by others using the HA-specific WHO reference assay (11, 17). The sensitivities of the SW-NS-631, SW-H1-1076, and IA M1 assays were comparable to those described by others (2).

The CT values of specimens collected during the first day of illness tended to be slightly higher than those of specimens taken 1 or 2 days later (data not shown). Thereafter, CT values gradually increased, an observations made also by others using PCR (2) or point-of-care tests (4). In contrast, To and coworkers (15) studied serial samples collected from patients infected with the pandemic virus and found the highest viral loads in specimens taken on the day of onset, with a gradual decrease thereafter.

Almost identical results were obtained when the SW-NS-631 (187 specimens) and IA M1 (56 specimens) assays were tested in parallel by the Helsinki University Hospital Laboratory Services (see Table S2 in the supplemental material), which indicates excellent reproducibility of the assays. Minor differences in the assay protocols at the two laboratories and possibly incomplete homogenization of specimens before dividing may explain minor discrepancies.

In the postpandemic area, the generic M gene-specific assay could serve as a primary diagnostic tool. Samples positive by this assay may then be tested by specific assays in order to identify the subtype of the virus. Additional tests are required to determine the neuraminidase (17) subtype and to identify possibly circulating reassortant viruses.

To our knowledge, no other assays amplifying parts of the NS gene have been described for the diagnostic detection of the influenza A (H1N1) 2009 virus. As this virus continues to circulate in some parts of the world and will likely establish itself as a seasonal influenza virus, thoroughly validated diagnostic procedures will be needed for years to come. The assays described here have been used for more than 1 year to test a substantial number of clinical specimens. Our results indicate that the assays described are highly specific and sensitive, which makes them valuable tools in the diagnostic work-up of clinical samples collected from individuals with influenza-like illness.

ACKNOWLEDGMENTS

The excellent technical assistance of Annamari Harberg and Anja Waroma is gratefully acknowledged.

Financial support for this study has been provided by the Ministry for Social Affairs and Health, Helsinki, Finland, and the Identification of Mechanisms Correlating with Susceptibility for Avian Influenza project (grant 201169), which is supported by European Commission DG Research and the participating member states.

None of us has any commercial or other association that poses a conflict of interest.

FOOTNOTES

    • Received 6 February 2011.
    • Returned for modification 10 February 2011.
    • Accepted 22 February 2011.
    • Accepted manuscript posted online 2 March 2011.
  • ↵† Supplemental material for this article may be found at http://dx.doi.org/10.1128/JCM.00259-11.

  • Copyright © 2011, American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Bautista E.,
    2. et al
    . 2010. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 362:1708–1719.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Cheng P. K.,
    2. et al
    . 2010. Performance of laboratory diagnostics for the detection of influenza A(H1N1)v virus as correlated with the time after symptom onset and viral load. J. Clin. Virol. 47:182–185.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Dawood F. S.,
    2. et al
    . 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360:2605–2615.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Gordon A.,
    2. et al
    . 2010. Diagnostic accuracy of a rapid influenza test for pandemic influenza A H1N1. PLoS One 5:e10364.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Ikonen N.,
    2. et al
    . 2010. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 15:19478.
    OpenUrlPubMed
  6. 6.↵
    1. Jain R.,
    2. Goldman R. D.
    . 2009. Novel influenza A(H1N1): clinical presentation, diagnosis, and management. Pediatr. Emerg. Care 25:791–796.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Jain S.,
    2. et al
    . 2009. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med. 361:1935–1944.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Medina R. A.,
    2. et al
    . 2011. Development and characterization of a highly specific and sensitive SYBR green reverse transcriptase PCR assay for detection of the 2009 pandemic H1N1 influenza virus on the basis of sequence signatures. J. Clin. Microbiol. 49:335–344.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Munster V. J.,
    2. et al
    . 2005. Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg. Infect. Dis. 11:1545–1551.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Osterlund P.,
    2. et al
    . 2010. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J. Virol. 84:1414–1422.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Peacey M.,
    2. Hall R. J.,
    3. Bocacao J.,
    4. Huang Q. S.
    . 2009. Diagnostic assay recommended by the World Health Organization for swine origin influenza A (H1N1) virus cross-reacts with H5N1 influenza virus. J. Clin. Microbiol. 47:3789–3790.
    OpenUrlFREE Full Text
  12. 12.↵
    1. Poon L. L.,
    2. et al
    . 2009. Molecular detection of a novel human influenza (H1N1) of pandemic potential by conventional and real-time quantitative RT-PCR assays. Clin. Chem. 55:1555–1558.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Schulze M.,
    2. Nitsche A.,
    3. Schweiger B.,
    4. Biere B.
    . 2010. Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR. PLoS One 5:e9966.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Selvaraju S. B.,
    2. Selvarangan R.
    . 2010. Evaluation of three influenza A and B real-time reverse transcription-PCR assays and a new 2009 H1N1 assay for detection of influenza viruses. J. Clin. Microbiol. 48:3870–3875.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. To K. K.,
    2. et al
    . 2010. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J. Med. Virol. 82:1–7.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Ward C. L.,
    2. et al
    . 2004. Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J. Clin. Virol. 29:179–188.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Yang Y.,
    2. et al
    . 2010. Simultaneous typing and HA/NA subtyping of influenza A and B viruses including the pandemic influenza A/H1N1 2009 by multiplex real-time RT-PCR. J. Virol. Methods 167:37–44.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Validation and Diagnostic Application of NS and HA Gene-Specific Real-Time Reverse Transcription-PCR Assays for Detection of 2009 Pandemic Influenza A (H1N1) Viruses in Clinical Specimens
Esa Rönkkö, Niina Ikonen, Mia Kontio, Minna Haanpää, Hannimari Kallio-Kokko, Laura Mannonen, Maija Lappalainen, Ilkka Julkunen, Thedi Ziegler
Journal of Clinical Microbiology Apr 2011, 49 (5) 2009-2011; DOI: 10.1128/JCM.00259-11

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Validation and Diagnostic Application of NS and HA Gene-Specific Real-Time Reverse Transcription-PCR Assays for Detection of 2009 Pandemic Influenza A (H1N1) Viruses in Clinical Specimens
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Validation and Diagnostic Application of NS and HA Gene-Specific Real-Time Reverse Transcription-PCR Assays for Detection of 2009 Pandemic Influenza A (H1N1) Viruses in Clinical Specimens
Esa Rönkkö, Niina Ikonen, Mia Kontio, Minna Haanpää, Hannimari Kallio-Kokko, Laura Mannonen, Maija Lappalainen, Ilkka Julkunen, Thedi Ziegler
Journal of Clinical Microbiology Apr 2011, 49 (5) 2009-2011; DOI: 10.1128/JCM.00259-11
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X